GCVCX
Price
$24.69
Change
-$0.04 (-0.16%)
Updated
Sep 8 closing price
Net Assets
551.5M
VIVAX
Price
$71.08
Change
-$0.13 (-0.18%)
Updated
Sep 8 closing price
Net Assets
202.84B
Interact to see
Advertisement

GCVCX vs VIVAX

Header iconGCVCX vs VIVAX Comparison
Open Charts GCVCX vs VIVAXBanner chart's image
Goldman Sachs Large Cp Val Insghts C
Price$24.69
Change-$0.04 (-0.16%)
VolumeN/A
Net Assets551.5M
Vanguard Value Index I
Price$71.08
Change-$0.13 (-0.18%)
VolumeN/A
Net Assets202.84B
GCVCX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GCVCX vs. VIVAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCVCX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 203B vs. GCVCX (551M). VIVAX pays higher dividends than GCVCX: VIVAX (1.99) vs GCVCX (0.22). GCVCX was incepted earlier than VIVAX: GCVCX (27 years) vs VIVAX (33 years). GCVCX (1.77) is less costly to investors than VIVAX (0.17). GCVCX is a more actively managed with annual turnover of: 206.00 vs. VIVAX (9.00). GCVCX has a lower initial minimum investment than VIVAX: GCVCX (1000) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 9.13 vs. GCVCX (-2.46). VIVAX return over 5 years is better than : 71.24 vs. GCVCX (27.63).
GCVCXVIVAXGCVCX / VIVAX
Total Expense Ratio1.670.17982%
Annual Report Gross Expense Ratio1.770.171,041%
Fund Existence27 years33 years-
Gain YTD8.1907.845104%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets551M203B0%
Annual Yield % from dividends0.221.9911%
Returns for 1 year-2.469.13-27%
Returns for 3 years15.2432.0348%
Returns for 5 years27.6371.2439%
Returns for 10 years60.75133.2346%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TATT35.521.70
+5.03%
TAT Technologies Ltd
SSBI11.840.04
+0.34%
Summit State Bank
JKHY162.530.29
+0.18%
Jack Henry & Associates
XRTX0.82N/A
N/A
XORTX Therapeutics
VSH15.38-0.18
-1.16%
Vishay Intertechnology